Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell - depleted bone marrow transplantation: A retrospective European survey from the European Group for Bone Marrow Transplantation and the European Society for Immunodeficiency

Journal of Pediatrics

Volumn 134, Issue 6, 1999, Pages 740-748

  Bertrand, Yves ^{a,b,c,d,e,f,g,h}   Landais, Paul ^{a,b,c,d,e,f,g,h}   Friedrich, Wilhelm ^{a,b,c,d,e,f,g,h}   Gerritsen, Bert ^{a,b,c,d,e,f,g,h}   Morgan, Gareth ^{a,b,c,d,e,f,g,h}   Fasth, Anders ^{a,b,c,d,e,f,g,h}   Cavazzana Calvo, Marina ^{a,b,c,d,e,f,g,h}   Porta, Fulvio ^{a,b,c,d,e,f,g,h}   Cant, Andrew ^{a,b,c,d,e,f,g,h}   Espanol, Theresa ^{a,b,c,d,e,f,g,h}   Müller, Susannah ^{a,b,c,d,e,f,g,h}   Veys, Paul ^{a,b,c,d,e,f,g,h}   Vossen, Jack ^{a,b,c,d,e,f,g,h}   Haddad, Elie ^{a,b,c,d,e,f,g,h}   Fischer, Alain ^{a,b,c,d,e,f,g,h}  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Unversitatskinderklinik/Poliklinik   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Hospital for Children   (United Kingdom)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF BRESCIA   (Italy)

^g NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^h HOSPITAL GENERAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; HLA ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; AGE; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; INFANT; LUNG INFECTION; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0033512908     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70291-X     Document Type: Article

References (27)

1. 1. WHO Scientific Group. Primary immunodeficiency diseases. Clin Exp Immunol 1997;109(suppl 1):S1-24.
2. 2. Griscelli C, Durandy A, Virelizier JL, Ballet JJ, Daguillard F. Selective defect of precursor T cells associated with apparently normal B lymphocytes in SCID. J Pediatr 1978;93:404-11.
3. 3. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;2:1366-9.
4. 4. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D and DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983;61:341-8.
5. 5. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
6. 6. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A, et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990;2:850-4.
7. 7. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint Basile G, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993;72:564-72.
8. 8. Friedrich W, Knobloch C, Greher J, Hartmann W, Peter HH, Goldmann, et al. Bone marrow transplantation in severe combined immunodeficiency: potential and current limitations. Immunodeficiency 1993;4:315-22.
9. 9. Buckley RH, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, et al. Development of immunity in severe primary T-cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986; 136:2398-407.
10. 10. Cowan MJ, Wara DW, Weintrub PS, Pabst H, Amman A. Haploidentical bone marrow transplantation for severe combined immunodeficiency using soybean agglutinin-negative, T-depleted marrow grafts. J Clin Immunol 1985;5:370-6.
11. 11. O'Reilly RJ, Keever CA, Small TN, Brochstein J. The use of HLA-nonidentical T-cell depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodeficiency Rev 1989;1:273-309.
12. 12. Haddad E, Landais P, Friedrich W, Gerritsen B, Morgan G, Bertrand Y, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study. Blood 1998;91:3646-53.
13. 13. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatly P, Hows J, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-8.
14. 14. Van Leeuwen JEM, van Tol MJD, Joosten AM, Schellekens PTA, Langlois van den Bergh R, Waaijer JLM, et al. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. Blood 1994;84:3936-47.
15. 15. LeDeist F, Thoenes G, Corado J, Lisowska-Grospierre B, Fischer A. Immunodeficiency with low expression of the T-cell receptor/CD3 complex: effect on T lymphocyte activation. Eur J Immunol 1991;21:1641-7.
16. 16. Dixon WJ, editor. BMDP statistical software. Berkeley: University of California Press; 1988.
17. 17. Buckley RH, Schiff SE, Schiff RI, Roberts JL, Markert ML, Peters W, et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 1993;30:92-8.
18. 18. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147-57.
19. 19. Macchi P, Villa A, Gillani S, Sacco MG, Frattini A, Porta F, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995;377:65-8.
20. 20. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, et al. RAG mutations in human B-cell negative SCID. Science 1996;274:97-8.
21. 21. Nicolas N, Finnie NJ, Cavazzana-Calvo M, Papadopoulo D, Le Deist F, Fischer A, et al. Lack of detectable defect in DNA double-stand break repair and DNA-dependent protein kinase activity in radiosensitive human severe combined immunodeficiency fibroblasts. Eur J Immunol 1996;26:1118-22.
22. 22. Cavazzana-Calvo M, Le Deist F, De Saint Basile G, Papadopoulo D, De Villartay JP, Fischer A. Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency. J Clin Invest 1993;91:1214-8.
23. 23. Peter HH, Friedrich W, Dopfer R, Muller W, Kortmann C, Pichler WJ, et al. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients. J Immunol 1983;131:2332-9.
24. 24. Kamel-Reid S, Dick JE. Engraftment of immune deficient mice with human hematopoietic stem cells. Science 1988;242:1706-11.
25. 25. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allograft by mice with severe combined immunodeficiency disease. J Exp Med 1987;165: 1212-7.
26. 26. Hale G, Cobbold S, Waldmann H. T cell depletion with campath-I for allogeneic bone marrow transplantation. Transplantation 1988;45:753-9.
27. 27. Cavazzana-Calvo M, Stephan JL, Sarnacki S, Chevret S, Fromont C, de Coene C, et al. Attenuation of graft-versus host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. Blood 1994;83:288-98.